Interview with patient suffering from the primary mitochondrial disease MELAS, and the treating physician. (English subtitles). Abliva (former NeuroVive), a Swedish pharmaceutical company, focuses on primary mitochondrial diseases that have few or no treatment options. Abliva has two first-in-class treatment strategies. Find out more at www.abliva.com.
- 4 жыл бұрын
Abliva Patient Interview - MELAS - primary mitochondrial disease
- Рет қаралды 3,413
Пікірлер: 4